gaitQ is a spinout from the University of Oxford that has its roots in the Department of Physiology, Anatomy and Genetics (DPAG) and the Institute of Biomedical Engineering (IBME). Our team is focussed on improving the lives of those with Parkinson's.
Around 45% of People with Parkinson's eventually develop gait-freezing, an intermittent failure to initiate or maintain walking – often described as the most debilitating symptom of the disease. gaitQ’s first product is a cueing device that helps individuals overcome gait-freezing episodes and maintain their levels of activity for longer. gaitQ features personalised, adaptive cueing during periods of gait-freezing in a discrete, unobtrusive device. Powered by proprietary machine learning algorithms, gaitQ’s technology has been in development for more than three years within Oxford University’s Institute of Biomedical Engineering (IBME) and the Department of Physiology Anatomy & Genetics (DPAG). A recent clinical study has demonstrated preliminary efficacy results showing a reduction in gait freezing events of 55%, a reduction of freeze duration of 73%, and an overall improvement in walking metrics.